LANTHEUS HOLDINGS INC (LNTH)
US5165441032 - Common Stock
Overall LNTH gets a fundamental rating of 7 out of 10. We evaluated LNTH against 187 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making LNTH a very profitable company, without any liquidiy or solvency issues. LNTH is growing strongly while it also seems undervalued. This is an interesting combination With these ratings, LNTH could be worth investigating further for value and growth and quality investing!.
1. Profitability
1.1 Basic Checks
LNTH had positive earnings in the past year.
LNTH had a positive operating cash flow in the past year.
In multiple years LNTH reported negative net income over the last 5 years.
LNTH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
LNTH has a better Return On Assets (20.86%) than 98.40% of its industry peers.
The Return On Equity of LNTH (36.25%) is better than 98.40% of its industry peers.
The Return On Invested Capital of LNTH (29.79%) is better than 99.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.86% | ||
| ROE | 36.25% | ||
| ROIC | 29.79% |
ROA(3y)4.55%
ROA(5y)3.98%
ROE(3y)10.32%
ROE(5y)11.2%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
LNTH has a better Profit Margin (28.57%) than 97.33% of its industry peers.
In the last couple of years the Profit Margin of LNTH has grown nicely.
LNTH's Operating Margin of 31.69% is amongst the best of the industry. LNTH outperforms 98.40% of its industry peers.
In the last couple of years the Operating Margin of LNTH has grown nicely.
Looking at the Gross Margin, with a value of 64.78%, LNTH is in the better half of the industry, outperforming 66.84% of the companies in the same industry.
LNTH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 31.69% | ||
| PM (TTM) | 28.57% | ||
| GM | 64.78% |
OM growth 3Y88.56%
OM growth 5Y16.03%
PM growth 3YN/A
PM growth 5Y16.4%
GM growth 3Y13.64%
GM growth 5Y4.73%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LNTH is creating value.
LNTH has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, LNTH has more shares outstanding
LNTH has a better debt/assets ratio than last year.
2.2 Solvency
LNTH has an Altman-Z score of 6.39. This indicates that LNTH is financially healthy and has little risk of bankruptcy at the moment.
LNTH has a Altman-Z score of 6.39. This is amongst the best in the industry. LNTH outperforms 82.89% of its industry peers.
LNTH has a debt to FCF ratio of 1.49. This is a very positive value and a sign of high solvency as it would only need 1.49 years to pay back of all of its debts.
LNTH's Debt to FCF ratio of 1.49 is amongst the best of the industry. LNTH outperforms 89.30% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that LNTH is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.00, LNTH is doing good in the industry, outperforming 67.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 1.49 | ||
| Altman-Z | 6.39 |
ROIC/WACC3.39
WACC8.8%
2.3 Liquidity
LNTH has a Current Ratio of 1.65. This is a normal value and indicates that LNTH is financially healthy and should not expect problems in meeting its short term obligations.
LNTH has a Current ratio of 1.65. This is in the lower half of the industry: LNTH underperforms 73.26% of its industry peers.
A Quick Ratio of 1.56 indicates that LNTH should not have too much problems paying its short term obligations.
The Quick ratio of LNTH (1.56) is comparable to the rest of the industry.
LNTH does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.65 | ||
| Quick Ratio | 1.56 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 18.63% over the past year.
The Earnings Per Share has been growing by 45.36% on average over the past years. This is a very strong growth
Looking at the last year, LNTH shows a very strong growth in Revenue. The Revenue has grown by 24.15%.
Measured over the past years, LNTH shows a very strong growth in Revenue. The Revenue has been growing by 30.43% on average per year.
EPS 1Y (TTM)18.63%
EPS 3Y121.92%
EPS 5Y45.36%
EPS Q2Q%15.65%
Revenue 1Y (TTM)24.15%
Revenue growth 3Y56.32%
Revenue growth 5Y30.43%
Sales Q2Q%18.37%
3.2 Future
The Earnings Per Share is expected to grow by 11.58% on average over the next years. This is quite good.
Based on estimates for the next years, LNTH will show a quite strong growth in Revenue. The Revenue will grow by 11.83% on average per year.
EPS Next Y10.02%
EPS Next 2Y6.09%
EPS Next 3Y8.32%
EPS Next 5Y11.58%
Revenue Next Year18.4%
Revenue Next 2Y11.17%
Revenue Next 3Y11.44%
Revenue Next 5Y11.83%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 12.87, LNTH is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of LNTH indicates a rather cheap valuation: LNTH is cheaper than 95.19% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.73. LNTH is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 12.73, which indicates a correct valuation of LNTH.
Based on the Price/Forward Earnings ratio, LNTH is valued cheaply inside the industry as 93.05% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, LNTH is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.87 | ||
| Fwd PE | 12.73 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LNTH is valued cheaper than 91.44% of the companies in the same industry.
93.58% of the companies in the same industry are more expensive than LNTH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.4 | ||
| EV/EBITDA | 11.01 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
LNTH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.28
PEG (5Y)0.28
EPS Next 2Y6.09%
EPS Next 3Y8.32%
5. Dividend
5.1 Amount
No dividends for LNTH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
LANTHEUS HOLDINGS INC
NASDAQ:LNTH (12/20/2024, 8:22:41 PM)
After market: 89.285 0 (0%)89.285
-2.66 (-2.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners101.09%
Inst Owner Change1.34%
Ins Owners1.46%
Ins Owner Change-1.9%
Market Cap6.21B
Analysts82.22
Price Target136.68 (53.08%)
Short Float %6.91%
Short Ratio4.34
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.75%
Min EPS beat(2)-3.57%
Max EPS beat(2)7.07%
EPS beat(4)3
Avg EPS beat(4)7.22%
Min EPS beat(4)-3.57%
Max EPS beat(4)18.05%
EPS beat(8)7
Avg EPS beat(8)13.42%
EPS beat(12)11
Avg EPS beat(12)25.14%
EPS beat(16)15
Avg EPS beat(16)92.7%
Revenue beat(2)1
Avg Revenue beat(2)0.5%
Min Revenue beat(2)-0.1%
Max Revenue beat(2)1.1%
Revenue beat(4)3
Avg Revenue beat(4)1.62%
Min Revenue beat(4)-0.1%
Max Revenue beat(4)4.1%
Revenue beat(8)6
Avg Revenue beat(8)2.5%
Revenue beat(12)10
Avg Revenue beat(12)5.64%
Revenue beat(16)14
Avg Revenue beat(16)4.97%
PT rev (1m)-7.3%
PT rev (3m)-5.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.6%
EPS NY rev (1m)0.6%
EPS NY rev (3m)0.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.49%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.87 | ||
| Fwd PE | 12.73 | ||
| P/S | 4.15 | ||
| P/FCF | 16.4 | ||
| P/OCF | 12.43 | ||
| P/B | 5.26 | ||
| P/tB | 6.57 | ||
| EV/EBITDA | 11.01 |
EPS(TTM)6.94
EY7.77%
EPS(NY)7.01
Fwd EY7.85%
FCF(TTM)5.45
FCFY6.1%
OCF(TTM)7.18
OCFY8.04%
SpS21.53
BVpS16.97
TBVpS13.59
PEG (NY)1.28
PEG (5Y)0.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.86% | ||
| ROE | 36.25% | ||
| ROCE | 37.48% | ||
| ROIC | 29.79% | ||
| ROICexc | 94.46% | ||
| ROICexgc | 229.39% | ||
| OM | 31.69% | ||
| PM (TTM) | 28.57% | ||
| GM | 64.78% | ||
| FCFM | 25.3% |
ROA(3y)4.55%
ROA(5y)3.98%
ROE(3y)10.32%
ROE(5y)11.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y135.85%
ROICexcg growth 5Y29.76%
ROICexc growth 3Y189.36%
ROICexc growth 5Y23.7%
OM growth 3Y88.56%
OM growth 5Y16.03%
PM growth 3YN/A
PM growth 5Y16.4%
GM growth 3Y13.64%
GM growth 5Y4.73%
F-Score6
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 1.49 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 193.42% | ||
| Cap/Sales | 8.06% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 93.02% | ||
| Profit Quality | 88.54% | ||
| Current Ratio | 1.65 | ||
| Quick Ratio | 1.56 | ||
| Altman-Z | 6.39 |
F-Score6
WACC8.8%
ROIC/WACC3.39
Cap/Depr(3y)73.29%
Cap/Depr(5y)87.08%
Cap/Sales(3y)3.96%
Cap/Sales(5y)4.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.63%
EPS 3Y121.92%
EPS 5Y45.36%
EPS Q2Q%15.65%
EPS Next Y10.02%
EPS Next 2Y6.09%
EPS Next 3Y8.32%
EPS Next 5Y11.58%
Revenue 1Y (TTM)24.15%
Revenue growth 3Y56.32%
Revenue growth 5Y30.43%
Sales Q2Q%18.37%
Revenue Next Year18.4%
Revenue Next 2Y11.17%
Revenue Next 3Y11.44%
Revenue Next 5Y11.83%
EBIT growth 1Y152.98%
EBIT growth 3Y194.75%
EBIT growth 5Y51.34%
EBIT Next Year24.38%
EBIT Next 3Y13.28%
EBIT Next 5Y13.27%
FCF growth 1Y119.88%
FCF growth 3Y279.62%
FCF growth 5Y39.01%
OCF growth 1Y162.37%
OCF growth 3Y165.02%
OCF growth 5Y37.91%